Anondita Medicare Ltd
Ticker: ANONDITA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
448.25
Market Cap
810.73
Debt/Equity
0.7014
ROE %
PB
20.7614
Promoter %
61.795
Pledge %
0.000
1Y Rev Growth %
5Y Rev Growth %
NP Margin %
20.485
NP Margin 5Y Avg %
Trading Reference
1M Return %
22.393
6M Return %
54.970
1Y Return %
54.970
% Away 52W High
6.012
% Away 52W Low
71.251
Daily Volume
106000
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Momentum
Score 83/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Anondita Medicare Ltd is currently facing resistance at the 200-day EMA, with support at the recent low. If it breaks above the resistance, there is potential for a 15% upside; however, if it fails to hold the support level, a downside of 10% is possible.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Banganga Paper Industries Ltd
Banganga Paper Industries Ltd shows potential in a growing sector but faces challenges in profitability and execution risks. Caution is advised for investors.
View details
S
S J Logistics (India) Ltd
S J Logistics shows potential for growth but faces challenges in profitability and market competition.
View details
R
RRP Defense Ltd
RRP Defense Ltd shows potential due to its positioning in a growing sector, but faces challenges in profitability and valuation metrics.
View details
S
Shraddha Prime Projects Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vertoz Ltd
Vertoz Ltd shows potential in a growing sector but faces significant challenges in profitability and valuation, making it a risky investment.
View details
T
Titan Biotech Ltd
Titan Biotech Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
View details
K
Kronox Lab Sciences Ltd
Kronox Lab Sciences Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
M
MBL Infrastructure Ltd
MBL Infrastructure Ltd presents significant risks with inconsistent growth and high debt levels, making it a risky investment.
View details
F
Focus Lighting and Fixtures Ltd
Focus Lighting and Fixtures Ltd shows potential in a growing sector, but faces significant challenges in profitability and market sentiment, making it a risky investment.
View details
I
IRIS Business Services Ltd
IRIS Business Services Ltd shows potential but faces challenges in growth consistency and market competition.
View details
M
Mahamaya Steel Industries Ltd
Mahamaya Steel Industries Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
View details
G
Gretex Corporate Services Ltd
Gretex Corporate Services Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
F
Fratelli Vineyards Ltd
Fratelli Vineyards Ltd shows potential in a growing sector, but faces challenges in profitability and valuation that warrant caution.
View details
A
Accent Microcell Ltd
Accent Microcell Ltd operates in a promising sector but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
View details
A
Artson Ltd
Artson Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
R
Repro India Ltd
Repro India Ltd shows potential in a transitioning sector but faces significant risks and inconsistent growth metrics.
View details
Business Overview
Anondita Medicare Ltd is a leading healthcare company dedicated to delivering high-quality medical products and services across India. Catering to hospitals, clinics, and healthcare professionals, Anondita aims to enhance patient care and improve health outcomes. With a strong focus on innovation and reliability, the company plays a crucial role in the evolving healthcare landscape.
- Established leader in the Indian healthcare sector
- Wide range of medical products and services
- Commitment to quality and patient care
- Innovative solutions for healthcare professionals
- Strong distribution network across India
Investment Thesis
Anondita Medicare Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to its peers. The company's strategic initiatives position it well for future growth, making it a worthy addition to any portfolio.
- Strong promoter group with a proven track record in the healthcare sector.
- Robust growth potential in digital health services, catering to evolving consumer needs.
- Attractive valuation metrics compared to industry peers, offering a favorable entry point.
- Commitment to innovation and technology integration enhances competitive advantage.
- Solid financial performance and growth outlook make it a reliable investment choice.
Opportunity vs Risk
Opportunities
- Growing healthcare sector in India
- Expansion into telemedicine services
- Strong government healthcare initiatives
- Rising demand for affordable medicines
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the market
- Supply chain disruptions
- Dependence on third-party suppliers
Peer Perspective
Anondita Medicare Ltd trades at a discount to peers like Sun Pharmaceutical and Dr. Reddy's Laboratories, reflecting concerns over margin stability; a consistent improvement in operational efficiency could trigger a rerating.
Future Outlook
Anondita Medicare Ltd is well-positioned for growth, driven by increasing demand for healthcare solutions. However, successful execution and stringent cost control will be crucial to maximize profitability and sustain momentum in the coming quarters.
AI FAQs for Retail Users
- Q: What does Anondita Medicare Ltd do?A: Anondita Medicare Ltd focuses on manufacturing and distributing pharmaceutical products and healthcare solutions.
- Q: Is Anondita Medicare Ltd a profitable company?A: Profitability can vary; it's best to check recent financial reports for the latest information.
- Q: What factors affect Anondita Medicare Ltd's stock price?A: Stock price can be influenced by market trends, company performance, and sector developments.
- Q: How can I invest in Anondita Medicare Ltd?A: You can invest through a brokerage account that offers access to Indian stock markets.
- Q: Are there any risks in investing in Anondita Medicare Ltd?A: Like all stocks, investing carries risks including market volatility and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
Anondita Medicare Ltd • Updated: 2025-09-16 19:31:12
-
8BusinessHighThe healthcare sector is growing, but the company's competitive edge is unclear.
-
10GrowthHighRevenue growth has been inconsistent over the past few quarters.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weaker profitability.
-
9ValuationHighP/E ratio is higher than peers, suggesting overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about disclosures.
-
5DriversGoodLimited growth catalysts identified, execution risks are high.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Anondita Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100